Skip to main content
Erschienen in: International Journal of Hematology 5/2015

01.05.2015 | Original Article

Clinical significance of nontuberculous mycobacteria from respiratory specimens in stem cell transplantation recipients

verfasst von: Ji Young Kang, Jick Hwan Ha, Hye Seon Kang, Hyoung-Kyu Yoon, Hee-Je Kim, Seok Lee, Dong-Gun Lee, Jung Im Jung, Seok Chan Kim, Young Kyoon Kim

Erschienen in: International Journal of Hematology | Ausgabe 5/2015

Einloggen, um Zugang zu erhalten

Abstract

The clinical importance of the isolation of nontuberculous mycobacteria (NTM) from respiratory specimens of stem cell transplant (SCT) recipients is not clear. We investigated the characteristics and clinical impact of NTM isolation in this population. Medical records of adult patients who underwent SCT at the blood and marrow transplantation center at a University Hospital in South Korea between January 2004 and December 2013 were retrospectively reviewed. Twenty-five of 2,658 patients were enrolled, an incidence of 0.94 %. The most common NTM species isolated were Mycobacterium avium complex (n = 15) and Mycobacterium abscessus (n = 5). Sixteen patients were co-infected with other pathogens, including Aspergillus species (10 cases). Nonspecific pneumonia and cavitary pneumonia were the most common radiologic patterns. Sixteen patients had underlying lung graft-versus-host disease, including bronchiolitis obliterans (10 cases) with moderate obstructive lung defects. Whereas two of 10 patients who were treated for NTM died as a result of NTM progression, one of 15 patients who were not treated died of the same cause. This study shows that the incidence of respiratory NTM detection in SCT recipients was low and its virulence was not higher than expected. As patients frequently had concomitant infections and underlying lung diseases that made radiologic evaluation more difficult, we suggest that it would be advantageous to perform repeated microbiologic studies when NTM infection is clinically suspected.
Literatur
1.
Zurück zum Zitat Philley JV, Griffith DE. Management of nontuberculous mycobacterial (NTM) lung disease. Semin Respir Crit Care Med. 2013;34:135–42.CrossRefPubMed Philley JV, Griffith DE. Management of nontuberculous mycobacterial (NTM) lung disease. Semin Respir Crit Care Med. 2013;34:135–42.CrossRefPubMed
2.
Zurück zum Zitat Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C, Gordin F, et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med. 2007;175:367–416.CrossRefPubMed Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C, Gordin F, et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med. 2007;175:367–416.CrossRefPubMed
3.
Zurück zum Zitat Lum LG, Seigneuret MC, Storb RF, Witherspoon RP, Thomas ED. In vitro regulation of immunoglobulin synthesis after marrow transplantation I. T-cell and B-cell deficiencies in patients with and without chronic graft-versus-host disease. Blood. 1981;58:431–9.PubMed Lum LG, Seigneuret MC, Storb RF, Witherspoon RP, Thomas ED. In vitro regulation of immunoglobulin synthesis after marrow transplantation I. T-cell and B-cell deficiencies in patients with and without chronic graft-versus-host disease. Blood. 1981;58:431–9.PubMed
4.
Zurück zum Zitat Atkinson K, Farewell V, Storb R, Tsoi MS, Sullivan KM, Witherspoon RP, et al. Analysis of late infections after human bone marrow transplantation: role of genotypic nonidentity between marrow donor and recipient and of nonspecific suppressor cells in patients with chronic graft-versus-host disease. Blood. 1982;60:714–20.PubMed Atkinson K, Farewell V, Storb R, Tsoi MS, Sullivan KM, Witherspoon RP, et al. Analysis of late infections after human bone marrow transplantation: role of genotypic nonidentity between marrow donor and recipient and of nonspecific suppressor cells in patients with chronic graft-versus-host disease. Blood. 1982;60:714–20.PubMed
5.
Zurück zum Zitat Weinstock DM, Feinstein MB, Sepkowitz KA, Jakubowski A. High rates of infection and colonization by nontuberculous mycobacteria after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transpl. 2003;31:1015–21.CrossRef Weinstock DM, Feinstein MB, Sepkowitz KA, Jakubowski A. High rates of infection and colonization by nontuberculous mycobacteria after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transpl. 2003;31:1015–21.CrossRef
6.
Zurück zum Zitat Simons S, van Ingen J, Hsueh PR, Van Hung N, Dekhuijzen PN, Boeree MJ, et al. Nontuberculous mycobacteria in respiratory tract infections, Eastern Asia. Emerg Infect Dis. 2011;17:343–9.CrossRefPubMedCentralPubMed Simons S, van Ingen J, Hsueh PR, Van Hung N, Dekhuijzen PN, Boeree MJ, et al. Nontuberculous mycobacteria in respiratory tract infections, Eastern Asia. Emerg Infect Dis. 2011;17:343–9.CrossRefPubMedCentralPubMed
7.
Zurück zum Zitat Koh WJ, Chang B, Jeong BH, Jeon K, Kim SY, Lee NY, et al. Increasing recovery of nontuberculous mycobacteria from respiratory specimens over a 10-year period in a tertiary referral hospital in South Korea. Tuberc Respir Dis (Seoul). 2013;75:199–204.CrossRef Koh WJ, Chang B, Jeong BH, Jeon K, Kim SY, Lee NY, et al. Increasing recovery of nontuberculous mycobacteria from respiratory specimens over a 10-year period in a tertiary referral hospital in South Korea. Tuberc Respir Dis (Seoul). 2013;75:199–204.CrossRef
8.
Zurück zum Zitat Diagnosis and treatment of disease caused by nontuberculous mycobacteria. This official statement of the American Thoracic Society was approved by the Board of Directors, March 1997. Medical Section of the American Lung Association. Am J Respir Crit Care Med. 1997;156:S1–S25. Diagnosis and treatment of disease caused by nontuberculous mycobacteria. This official statement of the American Thoracic Society was approved by the Board of Directors, March 1997. Medical Section of the American Lung Association. Am J Respir Crit Care Med. 1997;156:S1–S25.
9.
Zurück zum Zitat De Pauw B, Walsh TJ, Donnelly JP, Stevens DA, Edwards JE, Calandra T, et al. Revised definitions of invasive fungal disease from the European organization for research and treatment of cancer/invasive fungal infections cooperative group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis. 2008;46:1813–21.CrossRefPubMedCentralPubMed De Pauw B, Walsh TJ, Donnelly JP, Stevens DA, Edwards JE, Calandra T, et al. Revised definitions of invasive fungal disease from the European organization for research and treatment of cancer/invasive fungal infections cooperative group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis. 2008;46:1813–21.CrossRefPubMedCentralPubMed
10.
Zurück zum Zitat Filipovich AH, Weisdorf D, Pavletic S, Socie G, Wingard JR, Lee SJ, et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transpl. 2005;11:945–56.CrossRef Filipovich AH, Weisdorf D, Pavletic S, Socie G, Wingard JR, Lee SJ, et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transpl. 2005;11:945–56.CrossRef
11.
Zurück zum Zitat Uhlving HH, Buchvald F, Heilmann CJ, Nielsen KG, Gormsen M, Müller KG. Bronchiolitis obliterans after allo-SCT: clinical criteria and treatment options. Bone Marrow Transpl. 2012;47:1020–9.CrossRef Uhlving HH, Buchvald F, Heilmann CJ, Nielsen KG, Gormsen M, Müller KG. Bronchiolitis obliterans after allo-SCT: clinical criteria and treatment options. Bone Marrow Transpl. 2012;47:1020–9.CrossRef
12.
Zurück zum Zitat Chi AK, Soubani AO, White AC, Miller KB. An update on pulmonary complications of hematopoietic stem cell transplantation. Chest. 2013;144:1913–22.CrossRefPubMed Chi AK, Soubani AO, White AC, Miller KB. An update on pulmonary complications of hematopoietic stem cell transplantation. Chest. 2013;144:1913–22.CrossRefPubMed
13.
Zurück zum Zitat Unal E, Yen C, Saiman L, George D, Della-Latta P, van de Ven C, et al. A low incidence of nontuberculous mycobacterial infections in pediatric hematopoietic stem cell transplantation recipients. Biol Blood Marrow Transpl. 2006;12:1188–97.CrossRef Unal E, Yen C, Saiman L, George D, Della-Latta P, van de Ven C, et al. A low incidence of nontuberculous mycobacterial infections in pediatric hematopoietic stem cell transplantation recipients. Biol Blood Marrow Transpl. 2006;12:1188–97.CrossRef
14.
Zurück zum Zitat Au WY, Cheng VC, Ho PL, Yuen KY, Hung I, Ma SY, et al. Nontuberculous mycobacterial infections in Chinese hematopoietic stem cell transplantation recipients. Bone Marrow Transpl. 2003;32:709–14.CrossRef Au WY, Cheng VC, Ho PL, Yuen KY, Hung I, Ma SY, et al. Nontuberculous mycobacterial infections in Chinese hematopoietic stem cell transplantation recipients. Bone Marrow Transpl. 2003;32:709–14.CrossRef
15.
Zurück zum Zitat Chen CY, Sheng WH, Lai CC, Liao CH, Huang YT, Tsay W, et al. Mycobacterial infections in adult patients with hematological malignancy. Eur J Clin Microbiol Infect Dis. 2012;31:1059–66.CrossRefPubMed Chen CY, Sheng WH, Lai CC, Liao CH, Huang YT, Tsay W, et al. Mycobacterial infections in adult patients with hematological malignancy. Eur J Clin Microbiol Infect Dis. 2012;31:1059–66.CrossRefPubMed
16.
Zurück zum Zitat Kim HS, Lee Y, Lee S, Kim YA, Sun YK. Recent trends in clinically significant nontuberculous mycobacteria isolates at a Korean general hospital. Ann Lab Med. 2014;34:56–9.CrossRefPubMedCentralPubMed Kim HS, Lee Y, Lee S, Kim YA, Sun YK. Recent trends in clinically significant nontuberculous mycobacteria isolates at a Korean general hospital. Ann Lab Med. 2014;34:56–9.CrossRefPubMedCentralPubMed
17.
Zurück zum Zitat Kunst H, Wickremasinghe M, Wells A, Wilson R. Nontuberculous mycobacterial disease and aspergillus-related lung disease in bronchiectasis. Eur Respir J. 2006;28:352–7.CrossRefPubMed Kunst H, Wickremasinghe M, Wells A, Wilson R. Nontuberculous mycobacterial disease and aspergillus-related lung disease in bronchiectasis. Eur Respir J. 2006;28:352–7.CrossRefPubMed
18.
Zurück zum Zitat Böllert FG, Sime PJ, MacNee W, Crompton GK. Pulmonary Mycobacterium malmoense and aspergillus infection: a fatal combination? Thorax. 1994;49:521–2.CrossRefPubMedCentralPubMed Böllert FG, Sime PJ, MacNee W, Crompton GK. Pulmonary Mycobacterium malmoense and aspergillus infection: a fatal combination? Thorax. 1994;49:521–2.CrossRefPubMedCentralPubMed
19.
Zurück zum Zitat Hafeez I, Muers MF, Murphy SA, Evans EG, Barton RC, McWhinney P. Non-tuberculous mycobacterial lung infection complicated by chronic necrotising pulmonary aspergillosis. Thorax. 2000;55:717–9.CrossRefPubMedCentralPubMed Hafeez I, Muers MF, Murphy SA, Evans EG, Barton RC, McWhinney P. Non-tuberculous mycobacterial lung infection complicated by chronic necrotising pulmonary aspergillosis. Thorax. 2000;55:717–9.CrossRefPubMedCentralPubMed
20.
Zurück zum Zitat Lee Y, Song JW, Chae EJ, Lee HJ, Lee CW, Do KH, et al. CT findings of pulmonary non-tuberculous mycobacterial infection in non-AIDS immunocompromised patients: a case-controlled comparison with immunocompetent patients. Br J Radiol. 2013;86:20120209.CrossRefPubMedCentralPubMed Lee Y, Song JW, Chae EJ, Lee HJ, Lee CW, Do KH, et al. CT findings of pulmonary non-tuberculous mycobacterial infection in non-AIDS immunocompromised patients: a case-controlled comparison with immunocompetent patients. Br J Radiol. 2013;86:20120209.CrossRefPubMedCentralPubMed
21.
Zurück zum Zitat Gaviria JM, Garcia PJ, Garrido SM, Corey L, Boeckh M. Nontuberculous mycobacterial infections in hematopoietic stem cell transplant recipients: characteristics of respiratory and catheter-related infections. Biol Blood Marrow Transpl. 2000;6:361–9.CrossRef Gaviria JM, Garcia PJ, Garrido SM, Corey L, Boeckh M. Nontuberculous mycobacterial infections in hematopoietic stem cell transplant recipients: characteristics of respiratory and catheter-related infections. Biol Blood Marrow Transpl. 2000;6:361–9.CrossRef
Metadaten
Titel
Clinical significance of nontuberculous mycobacteria from respiratory specimens in stem cell transplantation recipients
verfasst von
Ji Young Kang
Jick Hwan Ha
Hye Seon Kang
Hyoung-Kyu Yoon
Hee-Je Kim
Seok Lee
Dong-Gun Lee
Jung Im Jung
Seok Chan Kim
Young Kyoon Kim
Publikationsdatum
01.05.2015
Verlag
Springer Japan
Erschienen in
International Journal of Hematology / Ausgabe 5/2015
Print ISSN: 0925-5710
Elektronische ISSN: 1865-3774
DOI
https://doi.org/10.1007/s12185-015-1745-9

Weitere Artikel der Ausgabe 5/2015

International Journal of Hematology 5/2015 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.